We are live on !
Find out more
Y-Intercept (HK) Portfolio holdings
AUM
$4.52B
Turnover
57.77%
1-Year Est. Return
6.6%
This Fund
S&P 500
This Quarter Est. Return
-2.41%
1 Year Est. Return
+6.6%
3 Year Est. Return
+41.57%
5 Year Est. Return
+18.6%
10 Year Est. Return
–
AUM
$4.52B
AUM Growth
-$528M
(-10%)
Cap. Flow
-$314M
Cap. Flow % of AUM
Cap. Flow %
-6.94%
Top 10 Holdings %
Top 10 Hldgs %
8.21%
Holding
2,238
New
587
Increased
481
Reduced
464
Closed
706
Avg Time Held
0.4
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Allstate
ALL
|
+$66.6M |
| 2 |
TSMC
TSM
|
+$34.9M |
| 3 |
Shopify
SHOP
|
+$29.2M |
| 4 |
Bank of America
BAC
|
+$28.4M |
| 5 |
Aon
AON
|
+$27.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$49.6M |
| 2 |
Boston Scientific
BSX
|
+$46M |
| 3 |
Microsoft
MSFT
|
+$44.5M |
| 4 |
Salesforce
CRM
|
+$37.3M |
| 5 |
Cognizant
CTSH
|
+$34.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 15.64% |
| 3 | Industrials | 12.53% |
| 4 | Healthcare | 11.61% |
| 5 | Consumer Discretionary | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Neurocrine Biosciences
NBIX
$14.6B
| $10.5M | 0.23% |
+73,778
| New | +$11.9M |
2026 Q3
0 quarters
|
|
77
ASE Group
ASX
$98.3B
| $10.3M | 0.23% |
+232,776
| New | +$9.12M |
2026 Q3
0 quarters
|
|
78
Analog Devices
ADI
$187B
| $10.3M | 0.23% |
26,062
+7,932
| +44% | +$2.99M |
2025 Q3
4 quarters
|
|
79
Broadcom
AVGO
$1.54T
| $10.3M | 0.23% |
29,381
-8,152
| -22% | -$3.07M |
2026 Q2
1 quarter
|
|
80
Teva Pharmaceutical Industries Limited
TEVA
$46.9B
| $10.2M | 0.23% |
+258,177
| New | +$9.23M |
2026 Q3
0 quarters
|
|
|
81
Cognizant
CTSH
$33.2B
| $10.2M | 0.23% |
177,809
-620,814
| -78% | -$34.1M |
2026 Q1
2 quarters
|
|
82
Expand Energy Corp
EXE
$21.5B
| $10M | 0.22% |
119,262
+92,330
| +343% | +$8.52M |
2025 Q4
3 quarters
|
|
83
Atlassian
TEAM
$56.5B
| $9.8M | 0.22% |
54,888
+49,400
| +900% | +$7.12M |
2024 Q3
8 quarters
|
|
84
Cboe Global Markets
CBOE
$34.2B
| $9.7M | 0.22% |
35,406
-77,815
| -69% | -$22.1M |
2025 Q4
3 quarters
|
|
85
W.R. Berkley
WRB
$28B
| $9.7M | 0.21% |
143,420
+87,683
| +157% | +$6.19M |
2025 Q4
3 quarters
|
|
86
VanEck Gold Miners ETF
GDX
$24.4B
| $9.6M | 0.21% |
109,684
+52,922
| +93% | +$4.62M |
2026 Q1
2 quarters
|
|
87
Medtronic
MDT
$124B
| $9.6M | 0.21% |
110,892
+105,744
| +2,054% | +$9.32M |
2025 Q3
4 quarters
|
|
88
Corteva
CTVA
$8.58B
| $9.44M | 0.21% |
+121,633
| New | +$10.1M |
2026 Q3
0 quarters
|
|
89
Baker Hughes
BKR
$53.2B
| $9.26M | 0.2% |
168,712
-43,740
| -21% | -$2.61M |
2026 Q2
1 quarter
|
|
90
HCA Healthcare
HCA
$101B
| $9.25M | 0.2% |
21,676
-10,562
| -33% | -$4.33M |
2025 Q2
5 quarters
|
|
91
Wheaton Precious Metals
WPM
$56.1B
| $9.23M | 0.2% |
68,991
+17,235
| +33% | +$2.28M |
2026 Q1
2 quarters
|
|
92
Insulet
PODD
$10.3B
| $9.11M | 0.2% |
69,856
+62,167
| +809% | +$9.3M |
2025 Q2
5 quarters
|
|
93
Genpact
G
$6.99B
| $9M | 0.2% |
276,568
+36,617
| +15% | +$1.24M |
2026 Q1
2 quarters
|
|
94
Alcoa
AA
$10.2B
| $8.9M | 0.2% |
211,838
+65,334
| +45% | +$3.12M |
2026 Q1
2 quarters
|
|
95
Omnicom Group
OMC
$22.7B
| $8.83M | 0.2% |
119,955
+28,596
| +31% | +$2.34M |
2026 Q2
1 quarter
|
|
96
Freeport-McMoran
FCX
$92.8B
| $8.82M | 0.2% |
126,041
-32,278
| -20% | -$2.2M |
2026 Q2
1 quarter
|
|
97
Curtiss-Wright
CW
$17.5B
| $8.75M | 0.19% |
+16,098
| New | +$10.6M |
2026 Q3
0 quarters
|
|
98
S&P Global
SPGI
$134B
| $8.73M | 0.19% |
22,135
+6,236
| +39% | +$2.64M |
2026 Q1
2 quarters
|
|
99
Darden Restaurants
DRI
$24.6B
| $8.7M | 0.19% |
45,004
+38,189
| +560% | +$7.98M |
2026 Q1
2 quarters
|
|
100
Argan
AGX
$4.63B
| $8.66M | 0.19% |
+22,914
| New | +$11.8M |
2026 Q3
0 quarters
|
|
Similar funds
Y-Intercept (HK)'s Q3 2026 Portfolio in Review
As of Q3 2026, Y-Intercept (HK) held 2,238 positions worth $4.52B, down 10% from $5.05B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
Y-Intercept (HK) withdrew a net $314M in Q3 2026, closing 706 positions and reducing 464 holdings. Its most notable exit was Microsoft, an estimated $44.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
Against the trend, Y-Intercept (HK) opened a new position in Allstate worth $58.3M.
- Y-Intercept (HK)'s largest Q3 2026 buy was Allstate: 262,728 shares worth $58.3M.
- Y-Intercept (HK) added most to TSMC in Q3 2026, an estimated $34.9M increase.
- Y-Intercept (HK)'s biggest Q3 2026 reduction was Amazon, cutting an estimated $49.6M.
- Y-Intercept (HK) fully exited Microsoft in Q3 2026, selling an estimated $44.5M.
- Y-Intercept (HK)'s ten largest holdings make up 8.2% of its $4.52B portfolio in Q3 2026.
- Y-Intercept (HK) opened 587 new positions and closed 706 in Q3 2026.
- Y-Intercept (HK)'s portfolio value fell 10% quarter-over-quarter to $4.52B.
Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.